Worth Venture Partners, LLC Insmed Inc Transaction History

Worth Venture Partners, LLC

  • $12 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$25.72 - $29.94 $396,088 - $461,076
15,400 New
15,400 $417,000
Q4 2017

Feb 01, 2018
SELL
$26.43 - $31.78 $804,899 - $967,828
-30,454 Closed
0 $0
Q3 2017

Nov 07, 2017
BUY
$11.61 - $31.21 $353,570 - $950,469
30,454
30,454 $950,000

Others Institutions Holding INSM

# of Institutions
447
Shares Held
170M
Call Options Held
5.79M
Put Options Held
5.18M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.87B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Worth Venture Partners, LLC Portfolio

Follow Worth Venture Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worth Venture Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email